Home | About | Donate

Report: Majority of Patients’ Groups Siding With Big Pharma Against Medicare Part B Pricing Reforms Receive Industry Funding


#1

Report: Majority of Patients’ Groups Siding With Big Pharma Against Medicare Part B Pricing Reforms Receive Industry Funding

Public Citizen

WASHINGTON - The overwhelming majority of patients’ groups opposing a Medicare Part B proposal to reduce drug expenditures got funding from the pharmaceutical industry, according to a new Public Citizen report.

The report, “Patients’ Groups and Big Pharma,” examined industry funding for 147 patients’ groups publicly opposing the Medicare Part B proposal, documenting disclosures of funding and sponsorships from the drug and medical device industry to 110 of those groups (75 percent of the total).

###